Basic Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 565-578
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.565
Figure 4
Figure 4 JOSD2 knockdown significantly suppresses the activity of esophageal squamous cell carcinoma cells. A: JOSD2 was successfully knocked down using shRNA1/2 directed against JOSD2 in KYSE150 cells; B: JOSD2 knockdown significantly inhibited cell proliferation; C: JOSD2 knockdown significantly inhibited the ability of the cells to form colonies. cP < 0.0001.